OPKO Health Gross Profit 2012-2025 | OPK

OPKO Health gross profit from 2012 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
OPKO Health Annual Gross Profit
(Millions of US $)
2024 $219
2023 $318
2022 $288
2021 $582
2020 $541
2019 $329
2018 $386
2017 $346
2016 $506
2015 $256
2014 $43
2013 $48
2012 $19
2011 $11
OPKO Health Quarterly Gross Profit
(Millions of US $)
2025-09-30 $50
2025-06-30 $49
2025-03-31 $43
2024-12-31 $85
2024-09-30 $40
2024-06-30 $52
2024-03-31 $42
2023-12-31 $45
2023-09-30 $48
2023-06-30 $126
2023-03-31 $99
2022-12-31 $56
2022-09-30 $31
2022-06-30 $116
2022-03-31 $85
2021-12-31 $109
2021-09-30 $142
2021-06-30 $150
2021-03-31 $182
2020-12-31 $176
2020-09-30 $155
2020-06-30 $139
2020-03-31 $71
2019-12-31 $82
2019-09-30 $87
2019-06-30 $82
2019-03-31 $78
2018-12-31 $72
2018-09-30 $99
2018-06-30 $114
2018-03-31 $101
2017-12-31 $4
2017-09-30 $95
2017-06-30 $135
2017-03-31 $112
2016-12-31 $12
2016-09-30 $147
2016-06-30 $204
2016-03-31 $144
2015-12-31 $133
2015-09-30 $76
2015-06-30 $28
2015-03-31 $20
2014-12-31 $14
2014-09-30 $9
2014-06-30 $11
2014-03-31 $10
2013-12-31 $9
2013-09-30 $9
2013-06-30 $11
2013-03-31 $20
2012-12-31 $7
2012-09-30 $4
2012-06-30 $4
2012-03-31 $4
2011-12-31 $2
2011-09-30 $3
2011-06-30 $4
2011-03-31 $3
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.044B $0.713B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $240.247B 28.55
Intuitive Surgical (ISRG) United States $188.491B 72.03
IDEXX Laboratories (IDXX) United States $55.181B 54.80
Edwards Lifesciences (EW) United States $49.001B 32.86
IQVIA Holdings (IQV) United States $40.710B 22.70
Alcon (ALC) Switzerland $40.074B 27.01
Mettler-Toledo (MTD) United States $29.378B 34.37
DexCom (DXCM) United States $28.830B 39.74
STERIS (STE) Ireland $25.607B 26.43
Waters (WAT) United States $23.844B 31.53
Coloplast (CLPBY) Denmark $19.494B 33.27
SONOVA HOLDING (SONVY) Switzerland $16.744B 0.00
Hologic (HOLX) United States $16.742B 17.59
Penumbra (PEN) United States $14.041B 98.77
Globus Medical (GMED) United States $12.667B 26.58
Masimo (MASI) United States $7.731B 24.77
Glaukos (GKOS) United States $7.231B 0.00
Sysmex ADR (SSMXY) Japan $6.112B 19.42
TransMedics (TMDX) United States $4.719B 55.91
Teleflex (TFX) United States $4.644B 7.40
LivaNova (LIVN) United Kingdom $3.488B 18.84
Veracyte (VCYT) United States $3.462B 39.46
Integer Holdings (ITGR) United States $2.997B 14.07
Elekta AB (EKTAY) Sweden $2.473B 23.14
Alphatec Holdings (ATEC) United States $2.347B 0.00
Artivion (AORT) United States $2.081B 95.48
UFP Technologies (UFPT) United States $2.057B 27.15
Nihon Kohden (NHNKY) Japan $2.028B 17.70
PROCEPT BioRobotics (PRCT) United States $1.717B 0.00
AxoGen (AXGN) United States $1.476B 0.00
Tandem Diabetes Care (TNDM) United States $1.396B 0.00
IRadimed (IRMD) United States $1.322B 62.96
Pulse Biosciences (PLSE) United States $0.986B 0.00
Integra LifeSciences Holdings (IART) United States $0.950B 5.14
Pacific Biosciences Of California (PACB) United States $0.806B 0.00
SiBone (SIBN) United States $0.734B 0.00
Beta Bionics (BBNX) United States $0.727B 0.00
Tactile Systems Technology (TCMD) United States $0.667B 38.78
Alpha Tau Medical (DRTS) Israel $0.608B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.608B 12.13
NeuroPace (NPCE) United States $0.568B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.548B 0.00
Mesa Laboratories (MLAB) United States $0.477B 13.18
OrthoPediatrics (KIDS) United States $0.464B 0.00
AngioDynamics (ANGO) United States $0.438B 0.00
RxSight (RXST) United States $0.405B 0.00
ClearPoint Neuro (CLPT) United States $0.404B 0.00
Delcath Systems (DCTH) United States $0.388B 64.59
Sight Sciences (SGHT) United States $0.339B 0.00
Semler Scientific (SMLR) United States $0.311B 2.32
Anteris Technologies Global (AVR) Australia $0.271B 0.00
Spectral Diagnostics (EDTXF) Canada $0.270B 0.00
908 Devices (MASS) United States $0.253B 0.00
Nano-X Imaging (NNOX) Israel $0.203B 0.00
Rapid Micro Biosystems (RPID) United States $0.195B 0.00
CVRx (CVRX) United States $0.172B 0.00
Treace Medical Concepts (TMCI) United States $0.171B 0.00
Inogen (INGN) United States $0.169B 0.00
Neuronetics (STIM) United States $0.151B 0.00
LENSAR (LNSR) United States $0.148B 0.00
Lucid Diagnostics (LUCD) United States $0.147B 0.00
Microbot Medical (MBOT) United States $0.136B 0.00
Zomedica (ZOMDF) United States $0.135B 0.00
EDAP TMS S.A (EDAP) France $0.133B 0.00
Solana (HSDT) United States $0.133B 0.00
Hyperfine (HYPR) United States $0.121B 0.00
Accuray (ARAY) United States $0.094B 0.00
Atossa Genetics (ATOS) United States $0.085B 0.00
Sensus Healthcare (SRTS) United States $0.082B 0.00
DarioHealth (DRIO) United States $0.079B 0.00
InspireMD (NSPR) United States $0.072B 0.00
QT Imaging Holdings (QTIH) United States $0.070B 0.00
Spectral AI (MDAI) United States $0.050B 0.00
Precision Optics (POCI) United States $0.039B 0.00
Baird Medical Investment Holdings (BDMD) $0.030B 0.00
Ekso Bionics Holdings (EKSO) United States $0.021B 0.00
Envoy Medical (COCH) United States $0.019B 0.00
Vicarious Surgical (RBOT) United States $0.016B 0.00
Adagio Medical Holdings (ADGM) United States $0.014B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.013B 0.00
NexGel (NXGL) United States $0.013B 0.00
Tenon Medical (TNON) United States $0.011B 0.00
PAVmed (PAVM) United States $0.011B 0.00
Check-Cap (MBAI) Israel $0.011B 0.00
EnVVeno Medical (NVNO) United States $0.007B 0.00
Nanovibronix (NAOV) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.004B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
Autonomix Medical (AMIX) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
ENvue Medical (FEED) United States $0.001B 0.00
WORK Medical Technology Group (WOK) China $0.000B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.000B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $0.000B 10.74